Interplay Between Non-Coding RNAs and Programmed Cell Death Proteins. 2022

Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
Department of Medical Genetics, School of Medicine, Shahid Beheshti Universality of Medical Sciences, Tehran, Iran.

Programmed cell death (PDCD) family of proteins includes at least 12 members, function of seven of them being more investigated. These members are PDCD1, PDCD2, PDCD4, PDCD5, PDCD6, PDCD7 and PDCD10. Consistent with the important roles of these proteins in the regulation of apoptosis, dysregulation of PDCDs is associated with diverse disorders ranging from intervertebral disc degeneration, amyotrophic lateral sclerosis, immune thrombocytopenia, type 1 diabetes, congenital hypothyroidism, Alzheimer's disease to different types of cancers. More recently, the interaction between non-coding RNAs and different members of PDCD family is being discovered. In the current study, we described the functional interactions between PDCDs and two classes of non-coding RNAs, namely microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). miR-21 and miR-183 are two miRNAs whose interactions with PDCDs have been assessed in different contexts. The lncRNAs interaction with PDCDs is mainly assessed in the context of neoplasia indicating the role of MALAT1, MEG3, SNHG14 and LINC00473 in this process.

UI MeSH Term Description Entries

Related Publications

Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
December 2022, Cancer letters,
Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
May 2021, RNA biology,
Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
January 2023, Frontiers in oncology,
Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
January 2023, The Journal of pharmacology and experimental therapeutics,
Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
June 2021, Journal of cellular and molecular medicine,
Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
December 2020, Journal of hematology & oncology,
Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
January 2019, Frontiers in oncology,
Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
July 2023, Journal of translational medicine,
Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
February 2022, Cancer communications (London, England),
Soudeh Ghafouri-Fard, and Bashdar Mahmud Hussen, and Mahdi Mohaqiq, and Hamed Shoorei, and Aria Baniahmad, and Mohammad Taheri, and Elena Jamali
January 2019, Frontiers in cell and developmental biology,
Copied contents to your clipboard!